Joris Wilms
SVP CHIEF OPERATING OFFICER · Y-mAbs Therapeutics, Inc.
Individual
- 2025
- Sep 16, 2025
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Joris Wilms's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Warren B. Kanders - $73.88M in CDRE purchases and sales in the last 12 months
- Amirali Talasaz - $73.75M in GH purchases and sales in the last 12 months
- L1 Capital Pty Ltd - $72.66M in AVR purchases and sales in the last 12 months
- James E. Flynn - $70.87M in NUVL purchases and sales in the last 12 months
- Joaquin Duato - $66.84M in JNJ purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $65.00M in TRAX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Joris Wilms?
Joris Wilms is a corporate insider, tracked as SVP CHIEF OPERATING OFFICER of Y-mAbs Therapeutics, Inc. (YMAB). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Joris Wilms last file a Form 4?
The only primary Form 4 on record is dated 16 September 2025.
